MedTrace Logo

EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Breast CA

NCT05747209 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2025-06-24

Study results available
· View outcomes & findings →

Summary

The goal of this clinical trial is to learn how a group resistance training plan can improve body mobility and strength in female breast cancer patients who have completed their breast cancer treatment. The main questions it aims to answer are:

* Is resistance training feasible following breast cancer treatment
* Can it improve the body's mobility and strength lost as a result of the breast cancer treatment
* can it improve the body's composition (for example muscle mass)
* can resistance training increase one's activity level and help prevent weight gain, perhaps, lowering the risk of cancer recurrence.

Participants will attend a group resistance training exercise group program, 3-4 times per week, under close supervision with monitoring a participant's ability to safely and effectively complete the program. The exercises include: lunges, squats and dead lifts.

Conditions

  • Breast Cancer Female

Interventions

OTHER

Observation of Exercise Program Adherence

Observation of a monitored group exercise regimen utilizing standard of care high-load resistance training and functional exercises with compound movements under close supervision and with the goal of improving functional mobility, body composition, and strength after cancer treatment to study adherence and attendance to the exercise program.

Sponsors & Collaborators

  • Colin Champ, MD

    lead OTHER

Principal Investigators

  • Colin Champ, MD · AGH Radiation Oncology

Eligibility

Min Age
20 Years
Max Age
89 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2024-08-13
Completion
2024-09-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05747209 on ClinicalTrials.gov